These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26763387)

  • 21. In vivo fluorescence-based characterization of cytochrome P450 activity during embryonic development of zebrafish (Danio rerio).
    Loerracher AK; Grethlein M; Braunbeck T
    Ecotoxicol Environ Saf; 2020 Apr; 192():110330. PubMed ID: 32078841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New cytochrome P450 1B1, 1C1, 2Aa, 2Y3, and 2K genes from Chinese rare minnow (Gobiocypris rarus): Molecular characterization, basal expression and response of rare minnow CYP1s and CYP2s mRNA exposed to the AHR agonist benzo[a]pyrene.
    Yuan L; Lv B; Zha J; Wang Z; Wang W; Li W; Zhu L
    Chemosphere; 2013 Sep; 93(2):209-16. PubMed ID: 23711412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of steroidogenesis and xenobiotic biotransformation responses in zebrafish (Danio rerio) exposed to water-soluble fraction of crude oil.
    Arukwe A; Nordtug T; Kortner TM; Mortensen AS; Brakstad OG
    Environ Res; 2008 Jul; 107(3):362-70. PubMed ID: 18396270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional profiling of cytochrome P450 genes in the liver of adult zebrafish, Danio rerio.
    Kubota A; Kawai YK; Yamashita N; Lee JS; Kondoh D; Zhang S; Nishi Y; Suzuki K; Kitazawa T; Teraoka H
    J Toxicol Sci; 2019; 44(5):347-356. PubMed ID: 31068540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zebrafish (Danio rerio): A valuable tool for predicting the metabolism of xenobiotics in humans?
    de Souza Anselmo C; Sardela VF; de Sousa VP; Pereira HMG
    Comp Biochem Physiol C Toxicol Pharmacol; 2018 Oct; 212():34-46. PubMed ID: 29969680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. III. Influence of CYP genetic polymorphism on population differentiation of drug metabolism phenotype.
    Tomaszewski P; Kubiak-Tomaszewska G; Łukaszkiewicz J; Pachecka J
    Acta Pol Pharm; 2008; 65(3):319-29. PubMed ID: 18646551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytochrome P450 (CYP) in fish.
    Uno T; Ishizuka M; Itakura T
    Environ Toxicol Pharmacol; 2012 Jul; 34(1):1-13. PubMed ID: 22418068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Some aspects of interindividual variations in the metabolism of xenobiotics.
    Tamási V; Vereczkey L; Falus A; Monostory K
    Inflamm Res; 2003 Aug; 52(8):322-33. PubMed ID: 14504670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in the expression of xenobiotic-metabolizing enzymes between islets derived from the ventral and dorsal anlage of the pancreas.
    Standop J; Ulrich AB; Schneider MB; Büchler MW; Pour PM
    Pancreatology; 2002; 2(6):510-8. PubMed ID: 12435863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytochrome P450 Structure, Function and Clinical Significance: A Review.
    Manikandan P; Nagini S
    Curr Drug Targets; 2018; 19(1):38-54. PubMed ID: 28124606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The evolution of our understanding of endo-xenobiotic crosstalk and cytochrome P450 regulation and the therapeutic implications.
    Tralau T; Luch A
    Expert Opin Drug Metab Toxicol; 2013 Dec; 9(12):1541-54. PubMed ID: 23941336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytochrome P450 5208A3 is a promiscuous xenobiotic biotransforming enzyme in Cunninghamella elegans.
    Khan MF; Murphy CD
    Enzyme Microb Technol; 2022 Nov; 161():110102. PubMed ID: 35917624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYP3C1, the first member of a new cytochrome P450 subfamily found in zebrafish (Danio rerio).
    Corley-Smith GE; Su HT; Wang-Buhler JL; Tseng HP; Hu CH; Hoang T; Chung WG; Buhler DR
    Biochem Biophys Res Commun; 2006 Feb; 340(4):1039-46. PubMed ID: 16414346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Vitro Biotransformation of Two Human CYP3A Probe Substrates and Their Inhibition during Early Zebrafish Development.
    Verbueken E; Alsop D; Saad MA; Pype C; Van Peer EM; Casteleyn CR; Van Ginneken CJ; Wilson J; Van Cruchten SJ
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Xenobiotic metabolizing cytochrome P450 in pig, a promising animal model.
    Puccinelli E; Gervasi PG; Longo V
    Curr Drug Metab; 2011 Jul; 12(6):507-25. PubMed ID: 21476973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytochrome P450 expression is moult stage specific and regulated by ecdysteroids and xenobiotics in the crab Carcinus maenas.
    Dam E; Rewitz KF; Styrishave B; Andersen O
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1135-40. PubMed ID: 18983823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional Analysis of the Unique Cytochrome P450 of the Liver Fluke Opisthorchis felineus.
    Pakharukova MY; Vavilin VA; Sripa B; Laha T; Brindley PJ; Mordvinov VA
    PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004258. PubMed ID: 26625139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cytochrome P450--its significance in the biotransformation of xenobiotics and interspecies comparisons].
    Hrubý K; Anzenbacher P
    Cesk Fysiol; 1997 Mar; 46(1):34-9. PubMed ID: 9221213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytochrome P450 20A1 in zebrafish: Cloning, regulation and potential involvement in hyperactivity disorders.
    Lemaire B; Kubota A; O'Meara CM; Lamb DC; Tanguay RL; Goldstone JV; Stegeman JJ
    Toxicol Appl Pharmacol; 2016 Apr; 296():73-84. PubMed ID: 26853319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.